CL2008000057A1 - Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo. - Google Patents

Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo.

Info

Publication number
CL2008000057A1
CL2008000057A1 CL200800057A CL2008000057A CL2008000057A1 CL 2008000057 A1 CL2008000057 A1 CL 2008000057A1 CL 200800057 A CL200800057 A CL 200800057A CL 2008000057 A CL2008000057 A CL 2008000057A CL 2008000057 A1 CL2008000057 A1 CL 2008000057A1
Authority
CL
Chile
Prior art keywords
enzyme
carbohydrate
relief
scan
treat
Prior art date
Application number
CL200800057A
Other languages
English (en)
Spanish (es)
Inventor
David M Anderson
Lin Liu
Humg-Yu Hsiao
Douglas W Fodge
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000057(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Publication of CL2008000057A1 publication Critical patent/CL2008000057A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL200800057A 1999-12-10 2008-01-09 Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo. CL2008000057A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
CL2008000057A1 true CL2008000057A1 (es) 2008-03-14

Family

ID=22617824

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800057A CL2008000057A1 (es) 1999-12-10 2008-01-09 Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo.

Country Status (31)

Country Link
US (2) US6780628B2 (enEXAMPLES)
EP (1) EP1239872B1 (enEXAMPLES)
JP (1) JP4871473B2 (enEXAMPLES)
KR (1) KR100639746B1 (enEXAMPLES)
CN (3) CN101327320A (enEXAMPLES)
AR (2) AR026764A1 (enEXAMPLES)
AT (1) ATE481981T1 (enEXAMPLES)
AU (1) AU782831B2 (enEXAMPLES)
BR (1) BRPI0016231B8 (enEXAMPLES)
CA (1) CA2394856C (enEXAMPLES)
CL (1) CL2008000057A1 (enEXAMPLES)
CO (1) CO5280226A1 (enEXAMPLES)
CR (1) CR6674A (enEXAMPLES)
CZ (1) CZ304925B6 (enEXAMPLES)
DE (1) DE60045010D1 (enEXAMPLES)
DK (1) DK1239872T3 (enEXAMPLES)
ES (1) ES2353371T3 (enEXAMPLES)
HU (1) HU230301B1 (enEXAMPLES)
IL (2) IL150048A0 (enEXAMPLES)
IN (1) IN247731B (enEXAMPLES)
MX (1) MX264033B (enEXAMPLES)
MY (1) MY124714A (enEXAMPLES)
NZ (1) NZ519404A (enEXAMPLES)
PH (1) PH12000003381B1 (enEXAMPLES)
PL (1) PL203054B1 (enEXAMPLES)
PT (1) PT1239872E (enEXAMPLES)
RU (1) RU2272419C2 (enEXAMPLES)
SK (1) SK287956B6 (enEXAMPLES)
TW (1) TWI255189B (enEXAMPLES)
UA (1) UA78486C2 (enEXAMPLES)
WO (1) WO2001041785A2 (enEXAMPLES)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
DK1973561T3 (da) 2005-12-15 2011-05-23 Chemgen Corp Enzymer til reducering af immunologisk stress
CA2636292C (en) * 2006-01-23 2011-04-19 Hill's Pet Nutrition, Inc. Methods for reducing food intake and controlling the weight of animals
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
KR20090087095A (ko) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 조직의 세포외공간에서 증가된 데옥시리보핵산 함량과 관련된 인간 질병을 치료하는 방법 및 이 방법을 수행하기 위한 약학 제제
ES2550685T3 (es) * 2007-06-08 2015-11-11 Australian Poultry Crc Pty Ltd Toxina clostridial NetB
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
RU2495098C2 (ru) * 2007-12-20 2013-10-10 ДАНИСКО ЮЖс ИНК. Способ ферментативного удаления биопленки, композиция и набор
DK2254591T3 (da) * 2008-02-08 2017-11-06 Prothera Inc Inhibering eller behandling af gastrointestinal biofilm
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
NZ626946A (en) 2012-02-16 2015-11-27 Lilly Co Eli Methods and compositions for reducing the environmental impact of animal waste
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
WO2016190780A1 (en) 2015-05-22 2016-12-01 Dmitry Dmitrievich Genkin Extracellular dna as a therapeutic target in neurodegeneration
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
EP3740581A4 (en) 2018-01-16 2021-10-27 CLS Therapeutics Limited TREATMENT OF DISEASES BY HEPATIC EXPRESSION OF AN ENZYME WHICH HAS DEOXYRIBONUCLEASE ACTIVITY (DNASE)
EP3759495A1 (en) * 2018-03-02 2021-01-06 Evonik Operations GmbH In vitro method for detecting intestinal barrier failure in animals
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
ES2114889T3 (es) 1990-05-29 1998-06-16 Chemgen Corp Suplemento de semicelulasa que mejora el rendimiento energetico de alimentos que contienen hemicelulosa y producto alimentario para animales.
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
JPH06511237A (ja) * 1991-07-24 1994-12-15 コ、トーマス　サイ　イーング 治療用組成物およびその製造方法
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
NL1003096C2 (nl) * 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) * 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
CN1235636A (zh) * 1996-10-31 1999-11-17 诺沃挪第克公司 新型磷脂酶,及其生产和应用
EP1121021A1 (en) 1998-10-15 2001-08-08 Dsm N.V. Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116029A1 (en) * 2001-02-20 2002-08-22 Victor Miller MRI-compatible pacemaker with power carrying photonic catheter and isolated pulse generating electronics providing VOO functionality

Also Published As

Publication number Publication date
AR089799A2 (es) 2014-09-17
US7723091B2 (en) 2010-05-25
MXPA02005735A (es) 2003-10-14
CA2394856A1 (en) 2001-06-14
JP4871473B2 (ja) 2012-02-08
AR026764A1 (es) 2003-02-26
MY124714A (en) 2006-06-30
SK8262002A3 (en) 2002-12-03
CR6674A (es) 2007-02-22
SK287956B6 (sk) 2012-07-03
CN102172262A (zh) 2011-09-07
UA78486C2 (uk) 2007-04-10
US20020048576A1 (en) 2002-04-25
PH12000003381B1 (en) 2010-04-16
CZ20022007A3 (cs) 2002-11-13
WO2001041785A2 (en) 2001-06-14
IN247731B (enEXAMPLES) 2011-05-13
AU782831B2 (en) 2005-09-01
HUP0203402A2 (hu) 2003-02-28
PL356175A1 (en) 2004-06-14
RU2272419C2 (ru) 2006-03-27
CA2394856C (en) 2011-05-10
CN1433319A (zh) 2003-07-30
PL203054B1 (pl) 2009-08-31
HUP0203402A3 (en) 2004-12-28
BRPI0016231B1 (pt) 2016-10-04
TWI255189B (en) 2006-05-21
EP1239872B1 (en) 2010-09-22
ATE481981T1 (de) 2010-10-15
HU230301B1 (hu) 2015-12-28
CN102172262B (zh) 2014-03-05
US20040223961A1 (en) 2004-11-11
DE60045010D1 (de) 2010-11-04
US6780628B2 (en) 2004-08-24
AU2577601A (en) 2001-06-18
IL150048A0 (en) 2002-12-01
IL150048A (en) 2016-09-29
ES2353371T3 (es) 2011-03-01
MX264033B (es) 2009-01-22
KR20020069204A (ko) 2002-08-29
BR0016231A (pt) 2003-06-24
JP2003520207A (ja) 2003-07-02
CO5280226A1 (es) 2003-05-30
BRPI0016231B8 (pt) 2021-05-25
WO2001041785A3 (en) 2002-01-24
PT1239872E (pt) 2010-12-03
EP1239872A2 (en) 2002-09-18
KR100639746B1 (ko) 2006-10-30
DK1239872T3 (da) 2010-10-25
IN2002DE00585A (enEXAMPLES) 2009-03-20
CN101327320A (zh) 2008-12-24
CZ304925B6 (cs) 2015-01-28
NZ519404A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
CL2008000057A1 (es) Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo.
ATE359040T1 (de) Implantat mit proliferationshemmender substanz
NO20013883L (no) Frysetörket middel inneholdende paramylon, samt fremstilling og anvendelse derav
ES2171564T3 (es) Metodo para explorar el riesgo de cancer gastrico.
NO995808L (no) Forbindelser, deres fremstilling og anvendelse for overfoering av nukleinsyrer inn i celler
BR0107643A (pt) Composições e processos para a terapia e diagnóstico de c ncer de próstata
IT1315841B1 (it) Catodo attivato e procedimento per la sua preparazione.
ES2192839T3 (es) Timosina beta 4 oxidada.
TR200100805T2 (tr) Tetrahidropiridoeterler
SI1764111T1 (sl) AntidisritmiŽŤna sredstva za vaginalno dajanje za zdravljenje materniŽŤne disritmije
IT1295183B1 (it) Macchina operatrice, e relativo procedimento, per la lavorazione di corpi piani.
NO994431L (no) Ny formulering
DE3786678D1 (de) Verbindungsstueck, insbesondere fuer medizinische zwecke.
DE59006562D1 (de) Endoskop, insbesondere Resektoskop.
NO913035L (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
WO1999051626A3 (en) Template associated npy y2-receptor agonists
ITMI20000919A0 (it) Procedimento per la manipolazione e il trasferimento di forme per il montaggio di calzature.
IT1307016B1 (it) Procedimento e dispositivo per la trasmissione di segnali numerici.
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
WO2003042240A3 (en) Polypeptides of pseudomonas aeruginosa
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа